Arrowhead Pharmaceuticals (ARWR) EBT Margin (2010 - 2026)
Arrowhead Pharmaceuticals (ARWR) posted EBT Margin of -237.74% for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 407.23 percentage points from -644.97% a year earlier but down 51.18 percentage points from the prior quarter.
Arrowhead Pharmaceuticals (ARWR) EBT Margin (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBT Margin at Arrowhead Pharmaceuticals was -37.65%, down 10.18 percentage points year-over-year; for FY2025 (ended Sep 30, 2025), it came in at 6.21%, up 17253.75 percentage points from FY2024.
- Annual EBT Margin shows a five-year change of +102.30 percentage points (FY2020 to FY2025).
- In prior fiscal years, Arrowhead Pharmaceuticals' EBT Margin was -17247.54% in FY2024 (-17161.76 pp), -85.78% in FY2023 (-14.77 pp), -71.01% in FY2022 (+30.84 pp) and -101.85% in FY2021 (-5.76 pp).
- Quarterly EBT Margin has run from a low of -7004.60% in fiscal Q1 2025 to a high of 68.11% in fiscal Q2 2025 over five years.
- On a year-over-year basis, EBT Margin increased in two of the last four quarters, with an average year-over-year change of +1017.23 percentage points.
- The strongest year-over-year quarter for EBT Margin in the past five years was fiscal Q1 2026, with a gain of 7015.31 percentage points; the weakest was fiscal Q1 2024, with a drop of 3838.81 percentage points.
- According to Business Quant data, EBT Margin for the three prior fiscal quarters was -186.56% (Q2 2026), 10.71% (Q1 2026) and 14.08% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Arrowhead Pharmaceuticals | 9.24 Bn | 4.02 Bn | - | -237.74% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -237.74% |
| Mar 31, 2026 | -186.56% |
| Dec 31, 2025 | 10.71% |
| Sep 30, 2025 | 14.08% |
| Jun 30, 2025 | -644.97% |
| Mar 31, 2025 | 68.11% |
| Dec 31, 2024 | -7,004.60% |
| Dec 31, 2023 | -3,905.63% |
| Sep 30, 2023 | -677.08% |
| Jun 30, 2023 | -653.29% |
| Mar 31, 2023 | 32.60% |
| Dec 31, 2022 | -66.82% |
| Sep 30, 2022 | -260.20% |
| Jun 30, 2022 | -222.28% |
| Mar 31, 2022 | 29.23% |
| Dec 31, 2021 | -229.13% |
| Sep 30, 2021 | -165.54% |
| Jun 30, 2021 | -65.21% |
| Mar 31, 2021 | -81.73% |
| Dec 31, 2020 | -97.32% |
Arrowhead Pharmaceuticals EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();